The overall and disease-free survival were significantly lower in the group with high expression of both genes than in the group with low expression of at least one gene (Fig. 7D, E), indicating that the combined detection of TCF7L2 and NEDD9 can well predict the prognosis of HCC patients. The gene discussed is NEDD9; the disease is hepatocellular carcinoma.